GlassScriptPhysician profile
Jay F Downey
NPI 1073610960
$5,043.78
in general payments reported to CMS, 2019-2025
37 companies · $687 in 2025
The $687 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $764 · 2021: $714 · 2022: $754 · 2023: $750 · 2024: $814 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,251.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $941.66 | 2020-2025 | Ubrelvy, Qulipta, Vraylar |
| Astrazeneca Pharmaceuticals LP | $670.48 | 2019-2025 | Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $511.98 | 2019-2025 | Trelegy Ellipta, Bexsero, Shingrix |
| Amarin Pharma, INC. | $364.84 | 2019-2022 | |
| Lilly USA, LLC | $261.02 | 2020-2024 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $245.59 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $212.16 | 2019-2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Pfizer INC. | $190.88 | 2022-2025 | |
| Amgen INC. | $173.74 | 2019-2024 | Repatha, Prolia, Evenity |
| Abbott Laboratories | $152.90 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Sanofi Pasteur INC. | $134.54 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $121.96 | 2022 | |
| Novo Nordisk INC | $119.36 | 2019-2025 | Ozempic, Rybelsus |
| Hologic Sales and Service, LLC | $114.92 | 2021-2025 | Thinprep 2000 Processor, Aptima |
| Dynavax Technologies Corporation | $106.50 | 2021-2024 | Heplisav-B |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Downey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.